摘要
目的探讨鲁南欣康治疗冠心病心绞痛的效果及对预后的影响。方法本次观察组选取60例冠心病心绞痛患者作为研究对象,均为我院2011年2月~2013年2月收治,采用鲁南欣康治疗,就临床资料与同期收治的对照组采用丹参注射液治疗的同类型60例患者临床资料进行对比。结果观察组选取病例中,总有效率为96.7%,显著高于对照组80.0%,差异有显著统计学意义(P【0.05)。两组治疗前心绞痛症状发作频率、发作持续时间无明显差异(P】0.05),治疗后两组均有一定程度的减少,但观察组减少幅度显著高于对照组,差异有统计学意义(P【0.05)。结论采用鲁南欣康治疗冠心病心绞痛,可显著提高临床总有效率,消除和改善症状,减少心绞痛发作及持续时间,获得理想预后,对患者生命健康提供了强有力的保障。
Objective Study of isosorbide mononitrate treatment of angina pectoris of coronary heart disease and influence on prognosis. Methods The observation group selected 60 cases of angina pectoris of coronary heart disease patients as research subjects, both in our hospital from 2011 February to 2013 February were treated with isosorbide mononitrate, treatment. Results Observation group selected cases, the total effective rate was 96.7%, significantly higher than that of the control group was 80.0%, there was significant difference (P<0.05). The two groups before treatment, symptoms of angina attack frequency, duration, no significant difference (P>0.05). Conclusion Using isosorbide mononitrate in treatment of angina pectoris, can significantly improve the clinical total effective rate, eliminate and improve symptoms,reduce the attack of angina pectoris and duration, to obtain the ideal prognosis, has provided the powerful safeguard for the patient's health and life.
出处
《中国药物经济学》
2013年第S1期240-241,共2页
China Journal of Pharmaceutical Economics
关键词
冠心病
心绞痛
鲁南欣康
预后
Coronary heart disease
Angina pectoris
Lunanxinkang
Prognosis
